Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Highly Active Antiretroviral Therapy Started during Pregnancy or Postpartum Suppresses HIV‐1 RNA, but Not DNA, in Breast Milk

5 Aug 2005

Abstract excerpt

BACKGROUND: The ability of highly active antiretroviral therapy (HAART) to reduce human immunodeficiency virus type 1 (HIV-1) RNA and DNA in breast milk has not been described. METHODS: We compared breast-milk HIV-1 RNA and DNA loads of women in Botswana who received HAART (nevirapine, lamivudine, and zidovudine) and women who did not receive HAART. RESULTS: Women in the HAART group received treatment for a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19 Impact on Reproduction
Share to HIV/AIDS Research and Interventions
Share to HIV Research and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 16088820
DOI: 10.1086/432489

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Highly Active Antiretroviral Therapy Started during Pregnancy or Postpartum Suppresses HIV‐1 RNA, but Not DNA, in Breast MilkPMID 16088820Read ↗

HIV-1 Concentrations in Human Breast Milk Before and After WeaningSemantic proximity Read ↗

Transmission of Cell-Free and Cell-Associated HIV-1 Through Breast-FeedingSemantic proximity Read ↗

Maternal Phenotype, Infant Size and Breast Milk Composition in Women Living With HIV.Semantic proximity Read ↗

Origin and evolution of HIV-1 in breast milk determined by single-genome amplification and sequencing.Semantic proximity Read ↗

Initiation of antiretroviral treatment in women after delivery can induce multiclass drug resistance in breastfeeding HIV-infected infants.Semantic proximity Read ↗

Viral and antiretroviral dynamics in HIV mother-to-child transmission fluids (VADICT) – Protocol and data analysis plan for a cohort studySemantic proximity Read ↗

Clonal amplification and maternal-infant transmission of nevirapine-resistant HIV-1 variants in breast milk following single-dose nevirapine prophylaxis.Semantic proximity Read ↗

Distribution of Kaposi Sarcoma–Associated Herpesvirus/Human Herpesvirus 8 in Maternal Saliva and Breast Milk in Zambia: Implications for TransmissionSemantic proximity Read ↗

Time to first positive HIV-1 DNA PCR may differ with antiretroviral regimen in infants infected with non-B subtype HIV-1.Semantic proximity Read ↗

Cell‐Free Human Immunodeficiency Virus Type 1 in Breast MilkSemantic proximity Read ↗

Preferential in-utero transmission of HIV-1 subtype C as compared to HIV-1 subtype A or D.Semantic proximity Read ↗

Compartmentalization of HIV-1 between breast milk and blood of HIV-infected mothers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.